Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma
- Resource Type
- Article
- Source
- In
European Journal of Cancer May 2012 48(7):1023-1030 - Subject
- Language
- ISSN
- 0959-8049